WGCA
BSX icon

Wolf Group Capital Advisors’s Boston Scientific BSX Stock Holding History

Wolf Group Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$2.14M Buy
+21,255
New +$2.14M 0.72% 41
2024
Q3 		– Sell
-21,971
Closed -$1.69M – 111
2024
Q2 		$1.69M Buy
+21,971
New +$1.61M 0.67% 55

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wolf Group Capital Advisors's BSX Position: Q1 2025 in Review

Wolf Group Capital Advisors opened a new position in Boston Scientific (BSX) in Q1 2025: 21,255 shares worth $2.14M. The stake represents 0.72% of the portfolio and ranks #41 among its holdings. This is a return to the name: Wolf Group Capital Advisors previously reported a position in BSX as recently as Q2 2024.

Wolf Group Capital Advisors first reported a position in BSX in Q2 2024 and has held it in 2 quarters since. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Wolf Group Capital Advisors held 21,255 shares of Boston Scientific worth $2.14M as of Q1 2025.
  • Boston Scientific was a new Wolf Group Capital Advisors position in Q1 2025.
  • Boston Scientific made up 0.72% of Wolf Group Capital Advisors's portfolio in Q1 2025, its #41 holding.
  • Wolf Group Capital Advisors first reported a position in Boston Scientific in Q2 2024 and has held it in 2 quarters since.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Wolf Group Capital Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.